Brief: 3D Medicines Inc - Proposed On-Market Share Repurchase Plan
Oct 4 (Reuters) - 3D Medicines Inc 1244.HK :
* PROPOSED ON-MARKET SHARE REPURCHASE PLAN
* APPROVED A PLAN TO EXERCISE GENERAL MANDATE TO REPURCHASE
SHARES
OF CO
* ALLOWED TO REPURCHASE UP TO 25.6 MILLION SHARES OF ISSUED
SHARES OF CO
* CONSIDERS THAT CURRENT TRADING PRICE OF SHARES DOES NOT
REFLECT
THEIR INTRINSIC VALUE
* CONSIDERS CURRENT TRADING PRICE OF SHARES DOES NOT REFLECT
ACTUAL BUSINESS PROSPECTS OF CO
* CONSIDERS CO'S OWN FINANCIAL RESOURCES WOULD ENABLE TO
CONDUCT
PROPOSED SHARE REPURCHASE PLAN
Further company coverage: 1244.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on 3D Medicines
See all newsArbitrator Dismisses Company's Claims In Arbitration Against 3D Medicines On July 24, 2026 - SEC Filing
Brief: 3D Medicines Updates On Arbitration Proceedings Against Sellas Life Sciences
Brief: 3D Medicines Inc Says Envafolimab Supplemental Application Accepted By NMPA
Brief: 3D Medicines Inc Says Zhang Jing Resigns As CFO
Brief: 3D Medicines Says New Drug Application For First-Line Treatment Of Biliary Tract Cancer Of Envafolimab Accepted